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The gag24 gene of the Human Immunodeficiency Virus type 1 (HIV-1) was expressed under the control 
of the tryptophan promoter in Escherichia coli. The effect of several parameters on the production of 
gag24 was studied. The expression level achieved (25%) depended on the host strain and the induction 
conditions. The developed fermentative process was scaled-up to 50 L, where 417 mg/L of volumetric 
production and 34 mg/L.h of productivity, were obtained. 
 





Escherichia coli is the most widely used prokaryotic 
system for the synthesis of heterologous protein due to 
its well-documented genetics and physiology (Panda, 
2003). Achieving high expression levels of target protein 
is one of the main objectives in the cultivation of 
recombinant cells. This objective may be accomplished 
through two complementary approaches, namely, genetic 
engineering and optimal induction. 
Different ways of inducing the expression of 
heterologous proteins cloned in E. coli under the ptrp 
system have been reported in the specialized literature 
(Yanofsky, 2003; Yanofsky, 2004). The most commonly 
used method is the use of competitive agents analogous 
to tryptophan, such as of β- indoleacrylic acid (IA), while 
the ptrp promoter can also be induced by derepression 
when the tryptophan present in the culture medium is 
depleted during the fermentation process (Bass and 
Yansura, 2000). 
In this article, we report the effect of the E. coli host 
strain, and the induction conditions (IA and tryptophan 
concentration) in the production of the recombinant 
gag24 protein, expressed under the control of tryptophan 
promoter. Finally the fermentation process developed to 
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describe  a   simple   and   highly   efficient   method   for  
obtaining large quantities of gag24, which can be used 




MATERIAL AND METHODS 
 
E. coli host strains and expression plasmid 
 
The following E. coli strains were used: HB-101 and W-3110 
(Sambrook et al., 2001). Bacteria were transformed with the 
pHIVCA-1 plasmid, which codes for the gag24 protein of HIV-1 
under the control of the tryptophan promoter (Novoa et al., 1994). 
 
 
Media composition and culture conditions 
 
Cultures were performed in shake flasks (G-25, New Brunswick 
Scientific Co.) or in a B.E. Marubishi fermenter (Japan), using M9 
medium (Miller, 1972) supplemented with glucose (5 g/L), casein 
hidrolysate (10 g/L), and 50 µg/mL of ampicillin. This formulation 
will be denominated hereafter basal medium (BM). The culture 
parameters were: 37°C and 250 rpm in shake flasks, and 37°C, 
aeration rate 1 vvm, pH 7.0, and stirrer speed 350 rpm, in the 50 L 
fermenter. In all cases the induction time was 12 h. The influence of 
host strain was determined using BM supplemented with 10 µg/mL 
of tryptophan. After 1 h of culture, 20 µg/mL IA was added as 
inductor. The effect of IA was determined by adding 20 µg/mL of 
tryptophan to the culture medium, and plus different concentrations of 
IA (between 0 to 60 µg/mL) added after 1 h of cultivation. The 
influence of the initial tryptophan concentrations (from 0 to 100 µg/mL) 
on protein expression was studied in the absence of IA in the culture 
medium. Finally the fermentation process developed to shake flasks 
level was scale up to pilot plant level using the kLa method. 




β Indoleacrilic Acid (µg/m L)

































































Figure 1. Effect of the IA concentration on the production of gag24. HB-101 (pHIVCA-1) 
transformed E. coli cells were grown in skake flasks using BM supplemented with 20 µg/mL of 
tryptophan. After 1 h of culture, IA was added as inductor for achieving concentrations ranging 
from 0 to 60 µg/mL. The cells were cultured for 12 h at 37°C and 250 rpm. 
 
 




Analytical methods  
 
Cellular mass was reported as dry weight (g/L). The glucose was 
determined by the DNSA method (Sumner and Somers, 1949). In 
all cases the expression level (concerning the total cellular protein) 
was carried out by densitometric analysis of SDS-PAGE (Laemmli, 
1970). The values of gag24 reported were determined multiplying 
the total protein concentration present in the culture medium 
(determined by the Lowry method (Lowry et al., 1951)) and the 
expression level. Each value corresponds to the average of at least 
3 independent production batches, and in each experiment at least 
3 assays were performed.  
 
 
RESULTS AND DISCUSSION 
 
Selection of the host strain 
 
In order to assess the effect of the host strain in the 
expression of gag24, different strains were transformed 
with the pHIVCA-1 plasmid and grown in shake flasks 
using BM supplemented with 10 µg/mL of tryptophan. 20 
µg/mL IA were added as inductor of the tryptophan 
expression, after 1 h of culture. 
Table 1 shows the strong host strain dependence of 
protein expression level, while the cellular growth was 
very similar in both cases. Similar results had been 
previously reported by our group when studying the 
expression of p36 protein from HIV-2 (Narciandi and 
Delgado, 1992), and a gene that codes for a fragment of 
the gp-41 transmembranic protein of HIV-1 (Narciandi et 
al., 1993), under the control of the tryptophan promoter. 
In the case of gag24, the highest yield was obtained 
using HB-101 (20% of the total cell protein). 
 
 
The effect of the induction conditions on the 
production of gag24 
 
The behavior of the expression of recombinant proteins 
expressed under the control of the tryptophan promoter 
depends on a series of factors, fundamentally the 
conditions of induction (Narciandi, 1996; Bass and 
Yansura, 2000).   
 
 
Effect of IA concentration 
 
The cells were grown in shake flasks. The BM was 
supplemented with 20 µg/mL of tryptophan. After 1 h of 
culture, concentrations of IA (between 0 to 60 µg/mL) were  
added as inductor, and the incubation continued during 
12 h at 37°C and 250 rpm. Figure 1 shows the effect of 
inductor concentration on the production of the gag24 
recombinant protein expressed under the control of 
tryptophan promoter. The expression level, the productivity 
and the volumetric production are a function of the amount 
of inductor utilized. Using 60 µg/mL of IA, 30% of 
expression was obtained, while using more than 40 µg/mL 
of IA, the productivity and the volumetric production reach 
their maximum value (35 mg/L.h and 423 mg/L 
respectively). The use of high concentrations of IA is limited  
Host strain  Dry weight (g/L) Expression Level (%) 
HB-101 1.44 ± 0.12 20 ± 2 
W-3110 1.47 ± 0.18 15 ± 3 







































































Figure 2. Effect of the tryptophan concentration on the production of gag24. HB-101 (pHIVCA-1) 
transformed E. coli cells were grown in skake flasks using BM supplemented with tryptophan 
concentrations ranging from 0 to 100 µg/mL in the absence of IA. The induction of gag24 expression 
was carried out by depleting the tryptophan present in the initial medium. The cells were cultured for 




to productive level due to their high cost. The cellular 
growth decreased only lightly upon increasing the 
concentration of the IA from 0 to 60 µg/mL. These results 
do not correspond with those reported in the literature, 
where concentrations higher than 25 µg/mL decreases 
drastically the cellurar growth, the productivity and the 
expression of the recombinant proteins (Calcott et al., 
1988).  
When the gag24 production was evaluated in the 
absence of IA, a maximum dry weight of 1.59 was 
obtained, and the other analyzed parameters decreased 
significantly in comparison with values reported when the 
inductor was used. This can be explained by the 
inhibiting effects of the initial amount of tryptophan in the 
culture medium (20 µg/mL) (Shimizu et al., 1991). 
 
 
Effect of tryptophan concentration 
 
The expression of gag24 was studied using initial culture 
medium tryptophan concentrations that ranged from 0 to 
100 µg/mL, and in the absence of IA. Figure 2 shows that 
the percentage of expression of the protein of interest 
decreased only slightly as the initial concentration of the 
repressor in the BM was increased from 0 to 10 µg/mL. 
However, concentrations above this level had inhibiting 
effects (Narciandi and Delgado, 1992; Pulliam et al., 
1997). Similar results were obtained when analyzing the 
productivity and the volumetric production of gag24. 
The best yields (420 mg/L of volumetric production, 35 
mg/L.h of productivity and 28% of expression) were 
obtained in absence of tryptophan, which is analogous to 
earlier report (Pulliam et al., 1997). Finally, cell mass was 
not noticiably affected in the presence of different 
tryptophan concentrations. These results are similar to 
the obtained using high concentrations of IA as inducer of 
the expression system. For this reason, the production of 
the gag24 protein was made by derepression of the 




Production kinetics of gag24 
 
Scaling up of the HB-101 (pHIVCA-1) culture was carried 
out at 50 L level, using BM in absence of tryptophan. 
Data from a typical batch culture of E. coli producing 
gag24 are shown in Figure 3. The cell dry weight and the 
expression level increased gradually during the time of 
cultivation (12 h), to a final value of 3.9 g/L and 25%, 
respectively. The specific growth rate in the logarithmic 
phase was 0.92 h-1. The productivity and the volumetric 
production had maximum yields after 12 h of culture (34 
mg/L.h, and 417 mg/L, respectively). This corresponds 
with the decrease of the carbon  source  (glucose) in   the  






















































































Figure 3. Kinetics of cell growth, product formation and substrate consumption. Scaling up of the HB-101 
(pHIVCA-1) culture was carried out at 50 L level, using BM in absence of tryptophan. The induction of 
gag24 expression was carried out by exhausting the tryptophan present in the initial medium. The cells 




medium. Similar results were obtained when the gag24 
protein was expressed in shake flasks, indicating that the 
scale up of the fermentative process was effective. These 
results are several fold better than those reported 
previously for the expression and production of gag24 (Mills 
and Jones, 1990; Tanaka et al., 1992; Marczinovits et al., 






In this report we demonstrate that a high yield in the 
production of gag24 recombinant protein expressed 
under the control of tryptophan promoter, depends on the 
host strains, and the tryptophan and IA concentrations 
used in the culture medium. The fermentation process 
developed was scaled up satisfactorily to pilot plant level. 
We describe a simple and highly efficient method for 
obtaining large quantities of gag24, which can be used 
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